Stock A263050 EUTILEX.CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Eutilex.Co.,Ltd

Equities

A263050

KR7263050007

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 10/06/2024 am IST 		5-day change 1st Jan Change
2,020 KRW -3.81% Intraday chart for Eutilex.Co.,Ltd -8.18% -40.24%
16/05 Eutilex.Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
21/03 Eutilex.Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Eutilex Co., Ltd. is a Korea-based company mainly engaged in the production and sale of immunotherapy products. Major products include anticancer T cell therapies and antibody therapies.

Sales per Business

KRW in Million2022Weight2023Weight Delta
T-cell Therapy and Antibody Therapeutics
100.0 %
216 100.0 % 132 100.0 % -38.95%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
70.1 %
216 100.0 % 92 70.1 % -57.18%
China
29.9 %
-- 39 29.9 % -

Managers

Managers TitleAgeSince
Soo-Young Choi CEO
 Chief Executive Officer 63 01/20/01
Byoung Kwon FOU
 Founder 77 27/15/27
Guk-Hee Lee AUD
 Comptroller/Controller/Auditor 76 01/16/01
Young-Ho Kim PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Yong-Sang Cho BRD
 Director/Board Member 77 28/18/28
Byoung Kwon FOU
 Founder 77 27/15/27
Myung-Hee Han BRD
 Director/Board Member 76 28/18/28
Young-Ho Kim PRN
 Corporate Officer/Principal - -
Bin Heo BRD
 Director/Board Member 48 -
Jang-Woo Park BRD
 Director/Board Member 75 01/18/01
Soo-Young Choi CEO
 Chief Executive Officer 63 01/20/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 47,471 0 2 ( 0.004213 %) 70.21 %
Stock B 1 36,798,858 25,836,762 ( 70.21 %) 0

Shareholders

NameEquities%Valuation
Byoung Kwon
10.89 %
4,006,860 10.89 % 6 M ₩
Myung-Hee Han
1.586 %
583,634 1.586 % 887 328 ₩
Hyung-joong Kwon
0.6848 %
251,992 0.6848 % 383 116 ₩
Yoo-joong Kwon
0.6848 %
251,992 0.6848 % 383 116 ₩
Myung-joong Kwon
0.6848 %
251,992 0.6848 % 383 116 ₩
EUTILEX.CO.,LTD
0.0108 %
3,977 0.0108 % 6 046 ₩
Young-Ho Kim
0.000000 %
0 0.000000 % - ₩
NameEquities%Valuation
EUTILEX.CO.,LTD
0.000067 %
2 0.000067 % 3 ₩

Holdings

NameEquities%Valuation
EUTILEX.CO.,LTD
0.01%
 3,977 0.01% 6,046 $

Company contact information

Eutilex Co., Ltd.

Suite 408 58 Gasan digital 1-ro

08591, Seoul

+

http://www.eutilex.com
address Eutilex.Co.,Ltd(A263050)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per region

Sector Biopharmaceuticals

1st Jan change Capi.
EUTILEX.CO.,LTD Stock Eutilex.Co.,Ltd
-40.24% 5.41Cr
CSL LIMITED Stock CSL Limited
-0.28% 9.23TCr
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
-3.16% 3.81TCr
UCB Stock UCB
+64.83% 2.65TCr
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-13.98% 1.57TCr
INCYTE CORPORATION Stock Incyte Corporation
-5.40% 1.34TCr
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-11.38% 1.17TCr
ALTEOGEN INC. Stock ALTEOGEN Inc.
+156.85% 977.87Cr
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-49.84% 1.01TCr
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+2.32% 883.9Cr
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. A263050 Stock
  4. Company Eutilex.Co.,Ltd